Announcements Trials
Browse Landscape

Phase

Phase 2 6Phase 3 3Phase NA 1Phase 2/3 1

Status

Recruiting 2Not yet recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Head & Neck 1Gastrointestinal 1

Conditions

Pathologic Complete Response 1Nasopharyngeal Carcinoma 1Anus Neoplasms 1

Interventions

pembrolizumab 223Carboplatin 217Cisplatin 205Paclitaxel 182Gemcitabine 149Docetaxel 127Capecitabine 114Dexamethasone 102Pemetrexed 101Cyclophosphamide 101Specimen Handling 99Magnetic Resonance Spectroscopy 97Oxaliplatin 96Radiotherapy 94Doxorubicin 90Fluorouracil 88Bevacizumab 83Nivolumab 74Leucovorin 73Rituximab 70durvalumab 66Vincristine 66Lenalidomide 64Irinotecan 61Etoposide 61atezolizumab 60Radiation 60130-nm albumin-bound paclitaxel 57Prednisone 56Letrozole 54

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 3 × Induction Chemotherapy × 1 year × Clear all
NCT05941741 2026-05-11

IC Plus Low-dose Radiation Plus Cadonilimab in LANPC

Sun Yat-sen University

Phase 3 Recruiting
380 enrolled
Head & Neck

Nasopharyngeal Carcinoma

NCT07472868 2026-03-16

MEND-IT II

Catharina Ziekenhuis Eindhoven

Phase 3 Not yet recruiting
394 enrolled

Pathologic Complete Response

NCT06207981 2025-09-02

KANALRAD

Federation Francophone de Cancerologie Digestive

Phase 3 Recruiting
310 enrolled
Gastrointestinal

Anus Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡